Figure 1.
Acute renal failure secondary to thrombotic microangiopathy after CMV viremia, at five months and nine months posttransplant, successfully treated with valganciclovir and eculizumab.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.